Medicare to cover select GLP-1 weight-loss drugs for $50 copay

Medicare has started covering certain GLP-1 weight-loss medications with a $50 copay, outlining which drugs are included and the eligibility criteria for beneficiaries. The policy aims to expand access to obesity treatments from manufacturers like Novo Nordisk and Eli Lilly, though coverage may depend on clinical indications and program details.